Publications

  1. Gits HC, Khosravi Flanigan MA, Kapplinger JD, Reisenauer JS, Eiken PW, Breen WG, Vu LH, Welch BT, Harmsen WS, Day CN, Olivier KR, Park SS, Garces YI, Hallemeier CL, Merrell KW, Ashman JB, Schild SE, Grams MP, Lucido JJ, Shen KR, Cassivi SD, Wigle D, Nichols FC, Blackmon S, Tapias LF, Callstrom MR, Owen D. Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy. Chest. 2024 May; 165 (5):1247-1259 Epub 2023 Dec 14
    View PubMed
  2. Pepin MD, Anaya S, Garces YI, Hosfield E, Lester SC, Ma DJ, Mundy DW, Neben-Wittich MA, Routman DM, Shonley C, Foote RL, Shiraishi S. Radiation Dose Sensitivity of Subregions of the Larynx to Patient-Reported Swallowing Outcomes. Adv Radiat Oncol. 2024 May; 9 (5):101458 Epub 2024 Feb 06
    View PubMed
  3. Pepin MD, Brost EE, Klein KA, Garces YI, Brinkmann DH. A script-enabled interactive checklist document for efficient management of electronic devices in a busy multimodality radiotherapy clinic. J Appl Clin Med Phys. 2024 Mar; 25 (3):e14302 Epub 2024 Feb 18
    View PubMed
  4. Foote RL, Harmsen WS, Amundson AC, Carr AB, Gamez ME, Garces YI, Lester SC, Ma DJ, McGee LA, Moore EJ, Neben Wittich MA, Patel SH, Routman DM, Rwigema JM, Van Abel KM, Yin LX, Muller OM, Shiraishi S. Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck Tumors. Cancers (Basel). 2024 Jan 13; 16 (2)
    View PubMed
  5. Hong S, Garces YI, Price KA, Shinya Y, Parney IF, Link MJ, Pollock BE. Treatment outcomes of single-fraction stereotactic radiosurgery for adenoid cystic carcinoma: a case series of 55 patients. J Neurooncol. 2024 Jan; 166 (2):369-376 Epub 2024 Jan 05
    View PubMed
  6. Madhavan S, Gamez M, Garces YI, Lester SC, Ma DJ, Mundy DW, Neben Wittich MA, Qian J, Routman DM, Foote RL, Shiraishi S. Impact of radiation dose distribution on nutritional supplementation needs in head and neck cancer radiotherapy: a voxel-based machine learning approach. Front Oncol. 2024; 14:1346797 Epub 2024 Feb 28
    View PubMed
  7. Weidhaas JB, Hu C, Komaki R, Masters GA, Blumenschein GR, Chang JY, Lu B, Dicker AP, Bogart JA, Garces YI, Narayan S, Robinson CG, Kavadi VS, Greenberger JS, Koprowski CD, Welsh J, Gore EM, MacRae RM, Paulus R, Bradley JD. The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC. Cancer Res Commun. 2023 Oct 11; 3 (10):2074-2081
    View PubMed
  8. Laughlin BS, Ebrahimi S, Voss MM, Patel SH, Foote RL, McGee LA, Garcia J, Ma DJ, Garces YI, Wittich MAN, Price KA, Schmitt A, Zhai Q, May BC, Nagel TH, Hinni ML, Chintakuntlawar AV, DeWees TA, Rwigema JM. Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience. Adv Radiat Oncol. 2023 Jul-Aug; 8 (4):101204 Epub 2023 Mar 01
    View PubMed
  9. Yu NY, DeWees TA, Voss MM, Breen WG, Chiang JS, Ding JX, Daniels TB, Owen D, Olivier KR, Garces YI, Park SS, Sarkaria JN, Yang P, Savvides PS, Ernani V, Liu W, Schild SE, Merrell KW, Sio TT. Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer. Clin Lung Cancer. 2022 Dec; 23 (8):e526-e535 Epub 2022 Aug 10
    View PubMed
  10. Price K, Van Abel KM, Moore EJ, Patel SH, Hinni ML, Chintakuntlawar AV, Graner D, Neben-Wittich M, Garces YI, Price DL, Janus JR, Foster NR, Ginos BF, Foote RL, Ma D. Long-Term Toxic Effects, Swallow Function, and Quality of Life on MC1273: A Phase 2 Study of Dose De-escalation for Adjuvant Chemoradiation in Human Papillomavirus-Positive Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys. 2022 Oct 1; 114 (2):256-265 Epub 2022 June 05
    View PubMed
  11. Gao RW, Day CN, Yu NY, Bush A, Amundson AC, Prodduturvar P, Majeed U, Butts E, Oliver T, Schwecke AJ, Moffett JN, Routman DM, Breen WG, Potter AL, Rivera-Concepcion J, Hoppe BS, Schild SE, Sio TT, Lou Y, Ernani V, Ko S, Olivier KR, Merrell KW, Garces YI, Manochakian R, Harmsen WS, Leventakos K, Owen D. Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab. Lung Cancer. 2022 Aug; 170:58-64 Epub 2022 June 13
    View PubMed
  12. Gao RW, Foote RL, Garces YI, Ma DJ, Neben-Wittich M, Routman DM, Patel SH, Ko SJ, McGee LA, Bible KC, Chintakuntlawar AV, Ryder M, Morris JC, Van Abel KM, Rivera M, Abraha F, Lester SC. Outcomes and Patterns of Recurrence for Anaplastic Thyroid Cancer Treated With Comprehensive Chemoradiotherapy. Pract Radiat Oncol. 2022 Mar-Apr; 12 (2):113-119 Epub 2021 Oct 26
    View PubMed
  13. Bridhikitti J, Viehman JK, Harmsen WS, Amundson AC, Shiraishi S, Mundy DW, Rwigema JM, McGee LA, Patel SH, Routman DM, Lester SC, Neben-Wittich MA, Garces YI, Ma DJ, Foote RL. Oncologic Outcomes for Head and Neck Skin Malignancies Treated with Protons. Int J Part Ther. 2021 Summer; 8 (1):294-303 Epub 2021 June 25
    View PubMed
  14. Waddle MR, Ma DJ, Visscher SL, Borah BJ, May JM, Price KA, Moore EJ, Patel SH, Hinni ML, Chintakuntlawar AV, Garcia JJ, Graner DE, Neben-Wittich MA, Garces YI, Hallemeier CL, Price DL, Kasperbauer JL, Janus JR, Foote RL, Miller RC. Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the Oropharynx. Int J Radiat Oncol Biol Phys. 2021 Jun 1; 110 (2):396-402 Epub 2020 Dec 23
    View PubMed
  15. Breen WG, Jeans EB, Gergelis KR, Garces YI, Park SS, Merrell KW, Peikert TD, Mansfield AS, Wigle DA, Harmsen WS, Ellerbusch DC, Olivier KR, John Lucido J, Owen D. Ablative radiotherapy for ultracentral lung cancers: Dosimetric, geometric, and volumetric predictors of outcomes and toxicity. Radiother Oncol. 2021 May; 158:246-252 Epub 2021 Mar 10
    View PubMed
  16. Zeng J, Badiyan SN, Garces YI, Wong T, Zhang X, Simone CB 2nd, Chang JY, Knopf AC, Mori S, Iwata H, Meijers A, Li H, Bues M, Liu W, Schild SE, Rengan R, International Particle Therapy Cooperative Group Thoracic Subcommittee. Consensus Statement on Proton Therapy in Mesothelioma. Pract Radiat Oncol. 2021 Mar-Apr; 11 (2):119-133 Epub 2020 May 24
    View PubMed
  17. Thor M, Deasy JO, Hu C, Gore E, Bar-Ad V, Robinson C, Wheatley M, Oh JH, Bogart J, Garces YI, Kavadi VS, Narayan S, Iyengar P, Witt JS, Welsh JW, Koprowski CD, Larner JM, Xiao Y, Bradley J. Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617. Clin Cancer Res. 2020 Sep 1; 26 (17):4643-4650 Epub 2020 May 12
    View PubMed
  18. Manzar GS, Lester SC, Routman DM, Harmsen WS, Petersen MM, Sloan JA, Mundy DW, Hunzeker AE, Amundson AC, Anderson JL, Patel SH, Garces YI, Halyard MY, McGee LA, Neben-Wittich MA, Ma DJ, Frank SJ, Whitaker TJ, Foote RL. Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer. Radiother Oncol. 2020 Jun; 147:64-74 Epub 2020 Mar 29
    View PubMed
  19. Evans JD, Harper RH, Petersen M, Harmsen WS, Anand A, Hunzeker A, Deiter NC, Schultz H, Jethwa KR, Lester SC, Routman DM, Ma DJ, Garces YI, Neben-Wittich MA, Laack NN, Beltran CJ, Patel SH, McGee LA, Rwigema JM, Mundy DW, Foote RL. The Importance of Verification CT-QA Scans in Patients Treated with IMPT for Head and Neck Cancers. Int J Part Ther. 2020 Summer; 7 (1):41-53 Epub 2020 Aug 03
    View PubMed
  20. Hughes JD, Young WF, Chang AY, Link MJ, Garces YI, Laack NN, Thompson GB, Pollock BE. Radiosurgical Management of Patients With Persistent or Recurrent Cushing Disease After Prior Transsphenoidal Surgery: A Management Algorithm Based on a 25-Year Experience. Neurosurgery. 2020 Apr 1; 86 (4):557-564
    View PubMed
  21. Breen WG, Garces YI, Olivier KR, Park SS, Merrell KW, Nichols FC, Peikert TD, Molina JR, Mansfield AS, Roden AC, Blackmon SH, Wigle DA. Surgery for Mesothelioma After Radiation Therapy (SMART); A Single Institution Experience. Front Oncol. 2020; 10:392 Epub 2020 Mar 24
    View PubMed
  22. Graffeo CS, Link MJ, Stafford SL, Garces YI, Foote RL, Pollock BE. More II It than Meets the Eye: Outcomes After Single-Fraction Stereotactic Radiosurgery in a Case Series of Low-Grade Arteriovenous Malformations. Oper Neurosurg (Hagerstown). 2020 Feb 1; 18 (2):136-144
    View PubMed
  23. Ma DJ, Price KA, Moore EJ, Patel SH, Hinni ML, Garcia JJ, Graner DE, Neben-Wittich M, Garces YI, Chintakuntlawar AV, Price DL, Van Abel KM, Kasperbauer JL, Janus JR, Waddle M, Miller RC, Shiraishi S, Mutter RW, Corbin KS, Park SS, Foote RL. Reply to A.S. Garden. J Clin Oncol 2019 Dec 20; 37 (36):3559-3560 Epub 2019 Sept 26
    View PubMed
  24. Chintakuntlawar AV, Yin J, Foote RL, Kasperbauer JL, Rivera M, Asmus E, Garces Y, Garces NI, Janus JR, Liu M, Ma DJ, Moore EJ, Morris JC 3rd, Neben-Wittich M, Price DL, Price KA, Ryder M, Van Abel KM, Hilger C, Samb E, Bible KC. A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer. Thyroid. 2019 Nov; 29 (11):1615-1622
    View PubMed
  25. Sio TT, Blanchard MJ, Novotny PJ, Patel SH, Rwigema JM, Pederson LD, McGee LA, Gamez ME, Seeger GR, Martenson JA, Grover Y, Neben Wittich MA, Garces YI, Foote RL, Miller RC, Halyard MY. N-Acetylcysteine Rinse for Thick Secretion and Mucositis of Head and Neck Chemoradiotherapy (Alliance MC13C2): A Double-Blind Randomized Clinical Trial. Mayo Clin Proc. 2019 Sep; 94 (9):1814-1824 Epub 2019 Aug 09
    View PubMed
  26. Ma DJ, Price KA, Moore EJ, Patel SH, Hinni ML, Garcia JJ, Graner DE, Foster NR, Ginos B, Neben-Wittich M, Garces YI, Chintakuntlawar AV, Price DL, Olsen KD, Van Abel KM, Kasperbauer JL, Janus JR, Waddle M, Miller R, Shiraishi S, Foote RL. Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell Carcinoma. J Clin Oncol. 2019 Aug 1; 37 (22):1909-1918 Epub 2019 June 04
    View PubMed
  27. Bezjak A, Paulus R, Gaspar LE, Timmerman RD, Straube WL, Ryan WF, Garces YI, Pu AT, Singh AK, Videtic GM, McGarry RC, Iyengar P, Pantarotto JR, Urbanic JJ, Sun AY, Daly ME, Grills IS, Sperduto P, Normolle DP, Bradley JD, Choy H. Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial. J Clin Oncol. 2019 May 20; 37 (15):1316-1325 Epub 2019 Apr 03
    View PubMed
  28. Arnett ALH, Mou B, Owen D, Park SS, Nelson K, Hallemeier CL, Sio T, Garces YI, Olivier KR, Merrell KW. Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLC. Adv Radiat Oncol. 2019 Apr-Jun; 4 (2):422-428 Epub 2019 Jan 24
    View PubMed
  29. Sio TT, Atherton PJ, Pederson LD, Zhen WK, Mutter RW, Garces YI, Ma DJ, Leenstra JL, Rwigema JM, Dakhil S, Bearden JD, van der Veen SJ, Ganti AK, Schild SE, Miller RC. Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial. Int J Radiat Oncol Biol Phys. 2019 Mar 1; 103 (3):686-696 Epub 2018 Nov 02
    View PubMed
  30. White DB, Hora MJ, Jenkins SM, Marks RS, Garces YI, Cassivi SD, Roden AC. Efficacy of chest computed tomography prediction of the pathological TNM stage of thymic epithelial tumours. Eur J Cardiothorac Surg. 2019 Feb 11 [Epub ahead of print]
    View PubMed
  31. Shiraishi S, Fong de Los Santos LE, Antolak JA, Olivier KR, Garces YI, Park SS, Grams MP. Phantom Verification of AAA and Acuros Dose Calculations for Lung Cancer: Do Tumor Size and Regression Matter? Pract Radiat Oncol. 2019 Jan; 9 (1):29-37 Epub 2018 Aug 20
    View PubMed
  32. Xie D, Allen MS, Marks R, Jiang G, Sun Z, Nichols F, Zhang M, Chen C, Aubry MC, Jatoi A, Garces YI, Mansfield A, Wigle D, Molina J, Deschamps C, Yang P. Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers. Eur J Cardiothorac Surg. 2018 Jun 1; 53 (6):1214-1222
    View PubMed
  33. Small W Jr, James JL, Moore TD, Fintel DJ, Lutz ST, Movsas B, Suntharalingam M, Garces YI, Ivker R, Moulder J, Pugh S, Berk LB. Utility of the ACE Inhibitor Captopril in Mitigating Radiation-associated Pulmonary Toxicity in Lung Cancer: Results From NRG Oncology RTOG 0123. Am J Clin Oncol. 2018 Apr; 41 (4):396-401
    View PubMed
  34. Hobbs CJ, Ko SJ, Paryani NN, Accurso JM, Olivier KR, Garces YI, Park SS, Hallemeier CL, Schild SE, Vora SA, Ashman JB, Rule WG, Bowers JR, Heckman MG, Diehl NN, Miller RC. Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non-Small Cell Lung Cancer: The Mayo Clinic Experience. Mayo Clin Proc Innov Qual Outcomes. 2018 Mar; 2 (1):40-48 Epub 2017 Dec 26
    View PubMed
  35. Prasongsook N, Kumar A, Chintakuntlawar AV, Foote RL, Kasperbauer J, Molina J, Garces Y, Ma D, Neben Wittich MA, Wittich MAN, Rubin J, Richardson R, Morris J, Hay I, Fatourechi V, McIver B, Ryder M, Thompson G, Grant C, Richards M, Sebo TJ, Rivera M, Suman V, Jenkins SM, Smallridge RC, Bible KC. Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer. J Clin Endocrinol Metab. 2017 Dec 1; 102 (12):4506-4514
    View PubMed
  36. Churilla TM, Ballman KV, Brown PD, Twohy EL, Jaeckle K, Farace E, Cerhan JH, Anderson SK, Carrero XW, Garces YI, Barker FG 2nd, Deming R, Dixon JG, Burri SH, Chung C, Menard C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL. Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial. Int J Radiat Oncol Biol Phys. 2017 Dec 1; 99 (5):1173-1178 Epub 2017 Aug 05
    View PubMed
  37. Arnett AL, Packard AT, Mara K, Mansfield AS, Wigle DA, Haddock MG, Park SS, Olivier KR, Garces YI, Merrell KW. FDG-PET parameters as predictors of pathologic response and nodal clearance in patients with stage III non-small cell lung cancer receiving neoadjuvant chemoradiation and surgery. Pract Radiat Oncol. 2017 Nov - Dec; 7 (6):e531-e541 Epub 2017 Apr 19
    View PubMed
  38. Leventakos K, Peikert T, Midthun DE, Molina JR, Blackmon S, Nichols FC, Garces YI, Hallemeier CL, Murphy SJ, Vasmatzis G, Kratz SL, Holland WP, Thomas CF, Mullon JJ, Shen KR, Cassivi SD, Marks RS, Aubry MC, Adjei AA, Yang P, Allen MS, Edell ES, Wigle D, Mansfield AS. Management of Multifocal Lung Cancer: Results of a Survey. J Thorac Oncol. 2017 Sep; 12 (9):1398-1402 Epub 2017 June 03
    View PubMed
  39. Schild SE, Hillman SL, Tan AD, Ross HJ, McGinnis WL, Garces YA, Graham DL, Adjei AA, Jett JR, Mayo Clinic, North Central Cancer Treatment Group. Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non-Small Cell Lung Cancer: NCCTG N0028 (Alliance). J Thorac Oncol. 2017 Apr; 12 (4):697-703 Epub 2017 Jan 12
    View PubMed
  40. Pollock BE, Link MJ, Stafford SL, Parney IF, Garces YI, Foote RL. The Risk of Radiation-Induced Tumors or Malignant Transformation After Single-Fraction Intracranial Radiosurgery: Results Based on a 25-Year Experience. Int J Radiat Oncol Biol Phys. 2017 Apr 1; 97 (5):919-923 Epub 2017 Jan 09
    View PubMed
  41. Pollock BE, Link MJ, Stafford SL, Lanzino G, Garces YI, Foote RL. Volume-Staged Stereotactic Radiosurgery for Intracranial Arteriovenous Malformations: Outcomes Based on an 18-Year Experience. Neurosurgery. 2017 Apr 1; 80 (4):543-550
    View PubMed
  42. Pollock BE, Storlie CB, Link MJ, Stafford SL, Garces YI, Foote RL. Comparative analysis of arteriovenous malformation grading scales in predicting outcomes after stereotactic radiosurgery. J Neurosurg. 2017 Mar; 126 (3):852-858 Epub 2016 Apr 08
    View PubMed
  43. Johnson GB, Aubry MC, Yi ES, Koo CW, Jenkins SM, Garces YI, Marks RS, Cassivi SD, Roden AC. Radiologic Response to Neoadjuvant Treatment Predicts Histologic Response in Thymic Epithelial Tumors. J Thorac Oncol. 2017 Feb; 12 (2):354-367 Epub 2016 Sept 22
    View PubMed
  44. Peacock JG, Harmsen WS, Link MJ, Van Gompel JJ, Giannini C, Olsen KD, Garces YI, Neben Wittich MA, Ma DJ, Park SS, Foote RL. Risk of Delayed Lymph Node Metastasis in Clinically N0 Esthesioneuroblastoma. J Neurol Surg B Skull Base. 2017 Feb; 78 (1):68-74 Epub 2016 July 06
    View PubMed
  45. Breen WG, Merrell KW, Mansfield AS, Wigle DA, Garces YI, Park SS, Olivier KR, Hallemeier CL. Predictors of relapse and evaluation of the role of postoperative radiation therapy in a modern series of patients with surgically resected stage III (N2) non-small cell lung cancer. Adv Radiat Oncol. 2017 Jan-Mar; 2 (1):12-18 Epub 2016 Dec 21
    View PubMed
  46. Reynolds MM, Arnett AL, Parney IF, Kumar R, Laack NN, Maloney PR, Kozelsky TF, Garces YI, Foote RL, Pulido JS. Gamma knife radiosurgery for the treatment of uveal melanoma and uveal metastases. Int J Retina Vitreous. 2017; 3:17 Epub 2017 May 29
    View PubMed
  47. Arnett AL, Packard AT, Garces YI, Merrell KW. P1.21: Novel PET Parameters as Predictors of Pathologic Response in Patients With Stage IIIA(N2) NSCLC Receiving Trimodality Therapy: Track: Early Stage NSCLC (Stage I - III). J Thorac Oncol. 2016 Oct; 11: (10S)S194-S195.
    View PubMed
  48. Mayo CS, Pisansky TM, Petersen IA, Yan ES, Davis BJ, Stafford SL, Garces YI, Miller RC, Martenson JA, Mutter RW, Choo R, Hallemeier CL, Laack NN, Ma DJ, Olivier KR, Keole SR, Fatyga M, Foote RL, Haddock MG. Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice review. Pract Radiat Oncol. 2016 Jul-Aug; 6 (4):e117-e126 Epub 2016 Jan 26
    View PubMed
  49. Sloan JA, Cheville AL, Liu H, Novotny PJ, Wampfler JA, Garces YI, Clark MM, Yang P. Impact of self-reported physical activity and health promotion behaviors on lung cancer survivorship. Health Qual Life Outcomes. 2016 Apr 29; 14:66
    View PubMed
  50. Pollock BE, Link MJ, Stafford SL, Garces YI, Foote RL. Stereotactic Radiosurgery for Arteriovenous Malformations: The Effect of Treatment Period on Patient Outcomes. Neurosurgery. 2016 Apr; 78 (4):499-509
    View PubMed
  51. Movsas B, Hu C, Sloan J, Bradley J, Komaki R, Masters G, Kavadi V, Narayan S, Michalski J, Johnson DW, Koprowski C, Curran WJ Jr, Garces YI, Gaur R, Wynn RB, Schallenkamp J, Gelblum DY, MacRae RM, Paulus R, Choy H. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial. JAMA Oncol. 2016 Mar; 2 (3):359-67
    View PubMed
  52. Owen D, Iqbal F, Pollock BE, Link MJ, Stien K, Garces YI, Brown PD, Foote RL. Long-term follow-up of stereotactic radiosurgery for head and neck malignancies. Head Neck. 2015 Nov; 37 (11):1557-62 Epub 2014 Aug 01
    View PubMed
  53. Courneyea L, Mullins J, Howard M, Foote R, Garces Y, Ma D, Beltran C, Brinkmann D, Pafundi D. Positioning reproducibility with and without rotational corrections for 2 head and neck immobilization systems. Pract Radiat Oncol. 2015 Nov-Dec; 5: (6)e575-81.
    View PubMed
  54. Stish BJ, Hallemeier CL, Olivier KR, Harmsen WS, Allen MS, Garces YI. Long-Term Outcomes and Patterns of Failure After Surgical Resection of Small-Cell Lung Cancer. Clin Lung Cancer. 2015 Sep; 16: (5)e67-73.
    View PubMed
  55. Xie D, Marks R, Zhang M, Jiang G, Jatoi A, Garces YI, Mansfield A, Molina J, Yang P. Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers. J Thorac Oncol. 2015 Aug; 10 (8):1213-20
    View PubMed
  56. Rollmann DC, Novotny PJ, Petersen IA, Garces YI, Bauer HJ, Yan ES, Wahner-Roedler D, Vincent A, Sloan JA, Issa Laack NN. Double-Blind, Placebo-Controlled Pilot Study of Processed Ultra Emu Oil Versus Placebo in the Prevention of Radiation Dermatitis. Int J Radiat Oncol Biol Phys. 2015 Jul 1; 92 (3):650-8 Epub 2015 Apr 28
    View PubMed
  57. Roden AC, Yi ES, Jenkins SM, Edwards KK, Donovan JL, Cassivi SD, Marks RS, Garces YI, Aubry MC. Modified Masaoka stage and size are independent prognostic predictors in thymoma and modified Masaoka stage is superior to histopathologic classifications. J Thorac Oncol. 2015 Apr; 10(4):691-700.
    View PubMed
  58. Roden AC, Yi ES, Jenkins SM, Edwards KK, Donovan JL, Lewis JE, Cassivi SD, Marks RS, Garces YI, Aubry MC. Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on prognosis. Am J Surg Pathol. 2015 Apr; 39(4):427-41.
    View PubMed
  59. Rule WG, Foster NR, Meyers JP, Ashman JB, Vora SA, Kozelsky TF, Garces YI, Urbanic JJ, Salama JK, Schild SE. Prophylactic cranial irradiation in elderly patients with small cell lung cancer: findings from a North Central Cancer Treatment Group pooled analysis. J Geriatr Oncol. 2015 Mar; 6 (2):119-26 Epub 2014 Dec 04
    View PubMed
  60. Owen D, Owen D, Olivier KR, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI. Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules. Radiat Oncol. 2015 Feb 18; 10:43
    View PubMed
  61. Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, Wynn RB, Koprowski C, Meng J, Beitler J, Gaur R, Curran W Jr, Choy H. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015 Feb; 16 (2):187-99 Epub 2015 Jan 16
    View PubMed
  62. Roden AC, Yi ES, Jenkins SM, Donovan JL, Cassivi SD, Garces YI, Marks RS, Aubry MC. Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas. Hum Pathol. 2015 Jan; 46: (1)17-25.
    View PubMed
  63. Stewart DJ, Chang DW, Ye Y, Spitz M, Lu C, Shu X, Wampfler JA, Marks RS, Garces YI, Yang P, Wu X. Wnt signaling pathway pharmacogenetics in non-small cell lung cancer. Pharmacogenomics J. 2014 Dec; 14(6):509-22. Epub 2014 Jul 01.
    View PubMed
  64. Grams MP, Fong de Los Santos LE, Brown LC, Mayo CS, Park SS, Garces YI, Olivier KR, Brinkmann DH. Separating the dosimetric consequences of changing tumor anatomy from positional uncertainty for conventionally fractionated lung cancer patients. Pract Radiat Oncol. 2014 Nov-Dec; 4 (6):455-65 Epub 2014 Apr 03
    View PubMed
  65. Sio TT, Jensen AR, Miller RC, Fong de los Santos LE, Hallemeier CL, Foster NR, Park SS, Bauer HJ, Chang K, Garces YI, Olivier KR. Influence of patient's physiologic factors and immobilization choice with stereotactic body radiotherapy for upper lung tumors. J Appl Clin Med Phys. 2014 Sep 8; 15 (5):4931 Epub 2014 Sept 08
    View PubMed
  66. Geiger JL, Lazim AF, Walsh FJ, Foote RL, Moore EJ, Okuno SH, Olsen KD, Kasperbauer JL, Price DL, Garces YI, Ma DJ, Neben-Wittich MA, Molina JR, Garcia JJ, Price KA. Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinoma. Oral Oncol. 2014 Apr; 50 (4):311-8 Epub 2014 Jan 24
    View PubMed
  67. Brown PD, Blanchard M, Jethwa K, Flemming KD, Brown CA, Kline RW, Jacobson DJ, St Sauver J, Pollock BE, Garces YI, Stafford SL, Link MJ, Erickson D, Foote RL, Laack NN. The incidence of cerebrovascular accidents and second brain tumors in patients with pituitary adenoma: a population-based study. Neurooncol Pract. 2014 Mar; 1 (1):22-28
    View PubMed
  68. Owen D, Laack NN, Mayo CS, Garces YI, Park SS, Bauer HJ, Nelson K, Miller RW, Brown PD, Olivier KR. Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases. Pract Radiat Oncol. 2014 Mar-Apr; 4 (2):e143-e149 Epub 2013 June 29
    View PubMed
  69. Clark MM, Atherton PJ, Lapid MI, Rausch SM, Frost MH, Cheville AL, Hanson JM, Garces YI, Brown PD, Sloan JA, Richardson JW, Piderman KM, Rummans TA. Caregivers of patients with cancer fatigue: a high level of symptom burden. Am J Hosp Palliat Care. 2014 Mar; 31 (2):121-5 Epub 2013 Feb 21
    View PubMed
  70. Grams MP, Brown LC, Brinkmann DH, Pafundi DH, Mundy DW, Garces YI, Park SS, Olivier KR, de los Santos LE. Analysis of automatic match results for cone-beam computed tomography localization of conventionally fractionated lung tumors. Pract Radiat Oncol. 2014 Jan-Feb; 4 (1):35-42 Epub 2013 Mar 26
    View PubMed
  71. Owen D, Olivier KR, Song L, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI. Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung. Front Oncol. 2014; 4:376 Epub 2015 Jan 14
    View PubMed
  72. Ahmed KA, Barney BM, Macdonald OK, Miller RC, Garces YI, Laack NN, Haddock MG, Foote RL, Olivier KR. Stereotactic body radiotherapy in the treatment of adrenal metastases. Am J Clin Oncol. 2013 Oct; 36 (5):509-13
    View PubMed
  73. Pollock BE, Stafford SL, Link MJ, Garces YI, Foote RL. Single-fraction radiosurgery of benign cavernous sinus meningiomas. J Neurosurg. 2013 Sep; 119 (3):675-82 Epub 2013 June 28
    View PubMed
  74. Stauder MC, Rooney JW, Neben-Wittich MA, Garces YI, Olivier KR. Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy. Radiat Oncol. 2013 Jul 06; 8:167.
    View PubMed
  75. Roden AC, Yi ES, Cassivi SD, Jenkins SM, Garces YI, Aubry MC. Clinicopathological features of thymic carcinomas and the impact of histopathological agreement on prognostical studies. Eur J Cardiothorac Surg. 2013 Jun; 43(6):1131-9. Epub 2012 Oct 19.
    View PubMed
  76. Hallemeier CL, Garces YI, Neben-Wittich MA, Olivier KR, Shon W, Garcia JJ, Brown PD, Foote RL. Adjuvant hypofractionated intensity modulated radiation therapy after resection of regional lymph node metastases in patients with cutaneous malignant melanoma of the head and neck. Pract Radiat Oncol. 2013 Apr-Jun; 3: (2)e71-7.
    View PubMed
  77. Cheville AL, Brinkmann DH, Ward SB, Durski J, Laack NN, Yan E, Schomberg PJ, Garces YI, Suman VJ, Petersen IA. The addition of SPECT/CT lymphoscintigraphy to breast cancer radiation planning spares lymph nodes critical for arm drainage. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85: (4)971-7.
    View PubMed
  78. Clark MM, Rummans TA, Atherton PJ, Cheville AL, Johnson ME, Frost MH, Miller JJ, Sloan JA, Graszer KM, Haas JG, Hanson JM, Garces YI, Piderman KM, Lapid MI, Netzel PJ, Richardson JW, Brown PD. Randomized controlled trial of maintaining quality of life during radiotherapy for advanced cancer. Cancer. 2013 Feb 15; 119 (4):880-7 Epub 2012 Aug 28
    View PubMed
  79. Hallemeier CL, Stauder MC, Miller RC, Garces YI, Foote RL, Sarkaria JN, Bauer HJ, Mayo CS, Olivier KR. Lung stereotactic body radiotherapy using a coplanar versus a non-coplanar beam technique: a comparison of clinical outcomes. J Radiosurg SBRT. 2013; 2 (3):225-233
    View PubMed
  80. Schild SE, Foster NR, Meyers JP, Ross HJ, Stella PJ, Garces YI, Olivier KR, Molina JR, Past LR, Adjei AA, North Central Cancer Treatment Group. Prophylactic cranial irradiation in small-cell lung cancer: findings from a North Central Cancer Treatment Group Pooled Analysis. Ann Oncol. 2012 Nov; 23 (11):2919-2924 Epub 2012 July 10
    View PubMed
  81. Schild SE, Foster NR, Meyers JP, Ross HJ, Stella PJ, Garces YI, Olivier KR, Molina JR, Past LR, Adjei AA, North Central Cancer Treatment Group. Prophylactic cranial irradiation in small-cell lung cancer: Findings from a North Central Cancer Treatment Group Pooled Analysis. Ann Oncol. 2012 Nov; 23 (11):2919-2924 Epub 2019 Dec 04
    View PubMed
  82. Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB. The clinical case for proton beam therapy. Radiat Oncol. 2012 Oct 22; 7:174
    View PubMed
  83. Buddula A, Assad DA, Salinas TJ, Garces YI, Volz JE, Weaver AL. Survival of dental implants in irradiated head and neck cancer patients: a retrospective analysis. Clin Implant Dent Relat Res. 2012 Oct; 14(5):716-22. Epub 2010 Oct 26.
    View PubMed
  84. Solberg Nes L, Liu H, Patten CA, Rausch SM, Sloan JA, Garces YI, Cheville AL, Yang P, Clark MM. Physical activity level and quality of life in long term lung cancer survivors. Lung Cancer. 2012 Sep; 77 (3):611-6 Epub 2012 June 06
    View PubMed
  85. Pollock BE, Stafford SL, Link MJ, Brown PD, Garces YI, Foote RL. Single-fraction radiosurgery of benign intracranial meningiomas. Neurosurgery. 2012 Sep; 71 (3):604-12; discussion 613
    View PubMed
  86. Pollock BE, Stafford SL, Link MJ, Garces YI, Foote RL. Single-fraction radiosurgery for presumed intracranial meningiomas: efficacy and complications from a 22-year experience. Int J Radiat Oncol Biol Phys. 2012 Aug 1; 83 (5):1414-8 Epub 2011 Dec 29
    View PubMed
  87. Sutherland JG, Furutani KM, Garces YI, Thomson RM. Model-based dose calculations for (125)I lung brachytherapy. Med Phys. 2012 Jul; 39 (7):4365-77
    View PubMed
  88. Chen J, Qi Y, Wampfler JA, Jatoi A, Garces YI, Busta AJ, Mandrekar SJ, Yang P. Effect of cigarette smoking on quality of life in small cell lung cancer patients. Eur J Cancer. 2012 Jul; 48(11):1593-601. Epub 2012 Jan 12.
    View PubMed
  89. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C. Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. J Oncol Pract. 2012 May; 8 (3 Suppl):e1s-5s
    View PubMed
  90. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C. Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. Am J Manag Care. 2012 May 1; 18 (5):e162-7 Epub 2012 May 01
    View PubMed
  91. Sloan JA, Zhao X, Novotny PJ, Wampfler J, Garces Y, Clark MM, Yang P. Relationship between deficits in overall quality of life and non-small-cell lung cancer survival. J Clin Oncol. 2012 May 1; 30 (13):1498-504 Epub 2012 Mar 26
    View PubMed
  92. Pollock BE, Stafford SL, Link MJ, Garces YI, Foote RL. Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience. Cancer. 2012 Feb 15; 118 (4):1048-54 Epub 2011 July 19
    View PubMed
  93. Yang P, Cheville AL, Wampfler JA, Garces YI, Jatoi A, Clark MM, Cassivi SD, Midthun DE, Marks RS, Aubry MC, Okuno SH, Williams BA, Nichols FC, Trastek VF, Sugimura H, Sarna L, Allen MS, Deschamps C, Sloan JA. Quality of life and symptom burden among long-term lung cancer survivors. J Thorac Oncol. 2012 Jan; 7 (1):64-70
    View PubMed
  94. Buddula A, Assad DA, Salinas TJ, Garces YI, Volz JE, Weaver AL. Survival of turned and roughened dental implants in irradiated head and neck cancer patients: a retrospective analysis. J Prosthet Dent. 2011 Nov; 106(5):290-6.
    View PubMed
  95. Wolfson AH, Bae K, Komaki R, Meyers C, Movsas B, Le Pechoux, Werner-Wasik M, Videtic GM, Garces YI, Choy H. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011 Sep 1; 81(1):77-84. Epub 2010 Aug 26.
    View PubMed
  96. Buddula A, Assad DA, Salinas TJ, Garces YI. Survival of dental implants in native and grafted bone in irradiated head and neck cancer patients: a retrospective analysis. Indian J Dent Res. 2011 Sep-Oct; 22: (5)644-8.
    View PubMed
  97. Pankratz VS, Sun Z, Aakre J, Li Y, Johnson C, Garces YI, Aubry MC, Molina JR, Wigle DA, Yang P. Systematic evaluation of genetic variants in three biological pathways on patient survival in low-stage non-small cell lung cancer. J Thorac Oncol. 2011 Sep; 6(9):1488-95.
    View PubMed
  98. Cheville AL, Novotny PJ, Sloan JA, Basford JR, Wampfler JA, Garces YI, Jatoi A, Yang P. The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors. J Pain Symptom Manage. 2011 Aug; 42 (2):213-21 Epub 2011 Mar 12
    View PubMed
  99. Cheville AL, Novotny PJ, Sloan JA, Basford JR, Wampfler JA, Garces YI, Jatoi A, Yang P. Fatigue, dyspnea, and cough comprise a persistent symptom cluster up to five years after diagnosis with lung cancer. J Pain Symptom Manage. 2011 Aug; 42 (2):202-12 Epub 2011 Mar 12
    View PubMed
  100. Garces YI, Patten CA, Sinicrope PS, Decker PA, Offord KP, Brown PD, Clark MM, Rummans TA, Foote RL, Hurt RD. Willingness of cancer patients to help family members to quit smoking. Psychooncology. 2011 Jul; 20(7):724-9. Epub 2010 May 20.
    View PubMed
  101. Stauder MC, Macdonald OK, Olivier KR, Call JA, Lafata K, Mayo CS, Miller RC, Brown PD, Bauer HJ, Garces YI. Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. Radiother Oncol. 2011 May; 99 (2):166-71 Epub 2011 May 14
    View PubMed
  102. Said SM, Sundt TM, Garces YI, Wigle DA. 5-year survival after multiple repeat metastasectomy for pulmonary artery angiosarcoma. Ann Thorac Surg. 2011 Apr; 91(4):e49-51.
    View PubMed
  103. Barney BM, Gillette BP, Garces YI, Ding W, Cheville JC, Rose PS. Myeloid sarcoma of the upper extremity causing compartment syndrome: a case report. Pract Radiat Oncol. 2011 Apr-Jun; 1: (2)135-8.
    View PubMed
  104. Chen J, Jiang R, Garces YI, Jatoi A, Stoddard SM, Sun Z, Marks RS, Liu Y, Yang P. Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients. Lung Cancer. 2010 Feb; 67 (2):221-6 Epub 2009 June 03
    View PubMed
  105. Macdonald OK, Kruse JJ, Miller JM, Garces YI, Brown PD, Miller RC, Foote RL. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis. Int J Radiat Oncol Biol Phys. 2009 Nov 1; 75 (3):950-8
    View PubMed
  106. Qi Y, Schild SE, Mandrekar SJ, Tan AD, Krook JE, Rowland KM, Garces YI, Soori GS, Adjei AA, Sloan JA. Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer. J Thorac Oncol. 2009 Sep; 4 (9):1075-82
    View PubMed
  107. Clark MM, Novotny PJ, Patten CA, Rausch SM, Garces YI, Jatoi A, Sloan JA, Yang P. Motivational readiness for physical activity and quality of life in long-term lung cancer survivors. Lung Cancer. 2008 Jul; 61 (1):117-22 Epub 2008 Feb 19
    View PubMed
  108. Price DL, Moore EJ, Friedman O, Garces YI, Kee AY, Furutani KM. Effect of radiation on segmental distraction osteogenesis in rabbits. Arch Facial Plast Surg. 2008 May-Jun; 10(3):159-63.
    View PubMed
  109. Pollock BE, Cochran J, Natt N, Brown PD, Erickson D, Link MJ, Garces YI, Foote RL, Stafford SL, Schomberg PJ. Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience. Int J Radiat Oncol Biol Phys. 2008 Apr 1; 70 (5):1325-9 Epub 2007 Oct 29
    View PubMed
  110. Shintani SA, Foote RL, Lowe VJ, Brown PD, Garces YI, Kasperbauer JL. Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008 Feb 1; 70(2):322-9. Epub 2007 Sep 24.
    View PubMed
  111. Garces YI, Schroeder DR, Nirelli LM, Croghan GA, Croghan IT, Foote RL, Hurt RD. Second primary tumors following tobacco dependence treatments among head and neck cancer patients. Am J Clin Oncol. 2007 Oct; 30(5):531-9.
    View PubMed
  112. Schild SE, Mandrekar SJ, Jatoi A, McGinnis WL, Stella PJ, Deming RL, Jett JR, Garces YI, Allen KL, Adjei AA, North Central Cancer Treatment GroupThis study was conducted as a collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic. The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer. Cancer. 2007 Jul 15; 110(2):363-8.
    View PubMed
  113. Garces YI, Okuno SH, Schild SE, Mandrekar SJ, Bot BM, Martens JM, Wender DB, Soori GS, Moore DF Jr, Kozelsky TF, Jett JR. Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67 (4):995-1001
    View PubMed
  114. Foote RL, Brown PD, Garces YI, Okuno SH, Miller RC, Strome SE. Informed consent in advanced laryngeal cancer. Head Neck. 2007 Mar; 29(3):230-5.
    View PubMed
  115. Schallenkamp JM, Miller RC, Brinkmann DH, Foote T, Garces YI. Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates. Int J Radiat Oncol Biol Phys. 2007 Feb 1; 67 (2):410-6
    View PubMed
  116. Foote RL, Foote RT, Brown PD, Garces YI, Okuno SH, Strome SE. Organ preservation for advanced laryngeal carcinoma. Head Neck. 2006 Aug; 28(8):689-96.
    View PubMed
  117. Krych AJ, Foote RL, Brown PD, Garces YI, Link MJ. Long-term results of irradiation for paraganglioma. Int J Radiat Oncol Biol Phys. 2006 Jul 15; 65(4):1063-6. Epub 2006 May 06.
    View PubMed
  118. Schild SE, McGinnis WL, Graham D, Hillman S, Fitch TR, Northfelt D, Garces YI, Shahidi H, Tschetter LK, Schaefer PL, Adjei A, Jett J. Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006 Jul 15; 65(4):1106-11. Epub 2006 May 26.
    View PubMed
  119. Jensen AW, Brown PD, Pollock BE, Stafford SL, Link MJ, Garces YI, Foote RL, Gorman DA, Schomberg PJ. Gamma knife radiosurgery of radiation-induced intracranial tumors: local control, outcomes, and complications. Int J Radiat Oncol Biol Phys. 2005 May 1; 62(1):32-7.
    View PubMed
  120. Krishnan S, Foote RL, Brown PD, Pollock BE, Link MJ, Garces YI. Radiosurgery for cranial base chordomas and chondrosarcomas. Neurosurgery. 2005 Apr; 56 (4):777-84; discussion 777-84
    View PubMed
  121. Ebbert JO, Williams BA, Sun Z, Aubry MC, Wampfler JA, Garces YI, Meyer RL, Yang P. Duration of smoking abstinence as a predictor for non-small-cell lung cancer survival in women. Lung Cancer. 2005 Feb; 47(2):165-72.
    View PubMed
  122. Foote RL, Kasperbauer JL, Okuno SH, Nichols DA, Olsen KD, Brown PD, Garces YI, Sargent DJ, Strome SE. A pilot study of high-dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3N0-N3M0 squamous cell carcinoma of the upper aerodigestive tract. Cancer. 2005 Feb 1; 103 (3):559-68
    View PubMed
  123. Garces YI, Yang P, Parkinson J, Zhao X, Wampfler JA, Ebbert JO, Sloan JA. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest. 2004 Dec; 126 (6):1733-41
    View PubMed
  124. Prisciandaro JI, Frechette CM, Herman MG, Brown PD, Garces YI, Foote RL. A methodology to determine margins by EPID measurements of patient setup variation and motion as applied to immobilization devices. Med Phys. 2004 Nov; 31 (11):2978-88
    View PubMed
  125. Foote RL, Pollock BE, Link MJ, Garces YI, Kline RW. Leksell Gamma Knife coordinate setting slippage: how often, how much? J Neurosurg. 2004 Oct; 101 (4):590-3
    View PubMed
  126. Svobodnik A, Yang P, Novotny PJ, Bass E, Garces YI, Jett JR, Bonner JA, Sloan JA. Quality of life in 650 lung cancer survivors 6 months to 4 years after diagnosis. Mayo Clin Proc. 2004 Aug; 79 (8):1024-30
    View PubMed
  127. Garces YI, Schroeder DR, Nirelli LM, Croghan GA, Croghan IT, Foote RL, Hurt RD. Tobacco use outcomes among patients with head and neck carcinoma treated for nicotine dependence: a matched-pair analysis. Cancer. 2004 Jul 1; 101(1):116-24.
    View PubMed
  128. Prisciandaro JI, Frechette CM, Brown PD, Foote RL, Garces YI, Herman MG. Methodology to compare planned margins with margins determined by EPID measurements of patient setup variation and motion. Am Assoc Phys Med. 2004; 31(11):2978-88.
  129. Foote RL, Brown PD, Garces YI, McIver B, Kasperbauer JL. Is there a role for radiation therapy in the management of Hurthle cell carcinoma? Int J Radiat Oncol Biol Phys. 2003 Jul 15; 56 (4):1067-72
    View PubMed
  130. Garces YI, Hays JT. Tobacco dependence: Why should an oncologist care? J Clin Oncol. 2003 May 1; 21(9):1884-6.
    View PubMed
  131. Kruse JJ, Herman MG, Hagness CR, Davis BJ, Garces YI, Haddock MG, Olivier KR, Stafford SL, Pisansky TM. Electronic and film portal images: a comparison of landmark visibility and review accuracy. Int J Radiat Oncol Biol Phys. 2002 Oct 1; 54 (2):584-91
    View PubMed
  132. Adler DG, Young-Fadok TM, Smyrk T, Garces YI, Baron TH. Preoperative chemoradiation therapy after placement of a self-expanding metal stent in a patient with an obstructing rectal cancer: clinical and pathologic findings. Gastrointest Endosc. 2002 Mar; 55: (3)435-7.
    View PubMed
  133. Pollock BE, Garces YI, Stafford SL, Foote RL, Schomberg PJ, Link MJ. Stereotactic radiosurgery for cavernous malformations. J Neurosurg. 2000 Dec; 93(6):987-91.
    View PubMed
  134. Jawahar A, Kondziolka D, Garces YI, Flickinger JC, Pollock BE, Lunsford LD. Stereotactic radiosurgery for hemangioblastomas of the brain. Acta Neurochir (Wien). 2000; 142: (6)641-4; discussion 644-5..
    View PubMed
  135. Bonner JA, Garces YI, Sawyer TE, Gould PM, Foote RL, Deschamps C, Lange CM, Li H. Frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma. Cancer. 1999 Oct 1; 86(7):1159-64.
    View PubMed
  136. Sawyer TE, Bonner JA, Gould PM, Garces YI, Foote RL, Lange CM, Li H. Predictors of subclinical nodal involvement in clinical stages I and II non-small cell lung cancer: implications in the inoperable and three-dimensional dose-escalation settings. Int J Radiat Oncol Biol Phys. 1999 Mar 15; 43 (5):965-70
    View PubMed
  137. Garces YI, Briley E, Felder C. Vasopressin V1a receptor stimulated phospholipase D: differential regulation of transphosphatidylation and phospholipid hydrolysis by protein kinase C. Neuropeptides. 1995; 28:277-85.
    View PubMed
  138. Garces YI, Rabito SF, Minshall RD, Sagen J. Lack of potent antinociceptive activity by substance P antagonist CP-96,345 in the rat spinal cord. Life Sciences. 1993; 52:353-60.
    View PubMed